TY  - JOUR
AU  - Toapanta, Nestor
AU  - Jimenez, Sara
AU  - Molina-Gomez, Maria
AU  - Maruri-Kareaga, Naroa
AU  - Llinas-Mallol, Laura
AU  - Villanego, Florentino
AU  - Facundo, Carme
AU  - Rodriguez-Ferrero, Marisa
AU  - Montero, Nuria
AU  - Vazquez-Sanchez, Teresa
AU  - Gutierrez-Dalmau, Alex
AU  - Beneyto, Isabel
AU  - Franco, Antonio
AU  - Hernandez-Vicente, Ana
AU  - Perez-Tamajon, M Lourdes
AU  - Martin, Paloma
AU  - Ramos-Verde, Ana Maria
AU  - Castañeda, Zaira
AU  - Bestard, Oriol
AU  - Moreso, Francesc
PY  - 2022
DO  - 10.1093/ckj/sfac112
SN  - 2048-8505
UR  - http://hdl.handle.net/10668/19749
T2  - Clinical kidney journal
AB  - Coronavirus disease 2019 (COVID-19) in kidney transplant recipients has a high risk of complications and mortality, especially in older recipients diagnosed during the early period after transplantation. Management of immunosuppression has been...
LA  - en
PB  - Oxford University Press
KW  - COVID-19 infection
KW  - Basiliximab
KW  - Lymphocyte-depleting agents
KW  - Renal transplantation
KW  - Kidney Transplantation
KW  - COVID-19
KW  - Immunosuppression Therapy
KW  - Registries
KW  - Demography
TI  - Induction immunosuppression and outcome in kidney transplant recipients with early COVID-19 after transplantation.
TY  - research article
VL  - 15
ER  -